Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Issues

Improved itch relief with new product formulation for topical treatment in patients with mild-to-moderate atopic dermatitis: results from an exploratory trial

Improved itch relief with new product formulation for topical treatment in patients with mild-to-moderate atopic dermatitis: results from an exploratory trial

Hans Stettler1*, Peter Kurka1, Rolf Dominicus2, Viktoria Pavel2, Marion Breuer2 and Holger Lenz1 1Bayer Consumer Care AG, Basel, Switzerland; 2Proinnovera GmbH, Muenster, Germany...

Flächentherapie mit Imiquimod 3,75 % erhält den höchsten Empfehlungsgrad

Flächentherapie mit Imiquimod 3,75 % erhält den höchsten Empfehlungsgrad

Neue internationale Leitlinie zur Behandlung der Aktinischen Keratose   Das Verständnis der Aktinischen Keratose (AK) hat sich dramatisch verändert: So weiß man heute, dass neben den klinisch...

Apremilast (OTEZLA®): eine effektive, orale Therapie gegen Versorgungsdefizite bei Psoriasis

Apremilast (OTEZLA®): eine effektive, orale Therapie gegen Versorgungsdefizite bei Psoriasis

Trotz wirksamer therapeutischer Möglichkeiten bestehen bei der Behandlung von Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis und/oder Psoriasis-Arthritis (PsA) große Defizite: Die...

General surgery

General surgery

More than 300 delegates and 36 speakers, representing Europe, America, the Middle East, Canada, Africa, Asia and Australia, convened in Berlin, Germany, in March 2015 for Smith & Nephew’s 6th...

The skin barrier and beyond

The skin barrier and beyond

Atopic dermatitis (AD) poses an enormous global burden, affecting 15–20% of children and 1–3% of adults worldwide.1 In the UK alone, it is estimated that over 1.2 million children aged <12...

Breast surgery

Breast surgery

More than 300 delegates and 36 speakers, representing Europe, America, the Middle East, Canada, Africa, Asia and Australia, convened in Berlin in March 2015 for Smith & Nephew’s 6th...

Orthopaedic surgery

Orthopaedic surgery

More than 300 delegates and 36 speakers, representing Europe, America, the Middle East, Canada, Africa, Asia and Australia, convened in Berlin, Germany, in March 2015 for Smith & Nephew’s 6th...

Kombinationstherapie Cobimetinib plus Vemurafenib zugelassen: Überzeugende Langzeitwirkung in allen Patientengruppen

Kombinationstherapie Cobimetinib plus Vemurafenib zugelassen: Überzeugende Langzeitwirkung in allen Patientengruppen

BRAFV600-Mutation-positives fortgeschrittenes Melanom Die im November 2015 europaweit erfolgte Zulassung des selektiven MEK-Inhibitors Cobimetinib (Cotellic®) in Kombination mit dem BRAF-Inhibitor...

Antihistaminika-refraktäre chronische spontane Urtikaria: Omalizumab reduziert Quaddeln, Juckreiz, Angioödeme und Alltagsbelastung

Antihistaminika-refraktäre chronische spontane Urtikaria: Omalizumab reduziert Quaddeln, Juckreiz, Angioödeme und Alltagsbelastung

Die chronische spontane Urtikaria ist mit einer hohen Krankheitslast verbunden und die Standardtherapien bringen oftmals keine Linderung. Das wurde auf der Jahrestagung der European Association of...

Second Spring Forum Haemophilia 2015

Second Spring Forum Haemophilia 2015

The 2nd Spring Forum Haemophilia 2015 – ‘New Avenues in Human rFVIII Replacement: Perspectives and Challenges for the Years Ahead’– was held in Berlin, Germany, on 17 and 18 April 2015. The...

1 … 21 22 23 24 25 … 38

Search Issues

RSS Feeds

  • All issues

Specialties

Click below to filter the KOM articles by specialty...

  • Allergy & Immunology
  • Cardiology
  • Conference
  • Critical Care
  • Dentistry
  • Dermatology
  • Diabetes & Endocrinology
  • Gastroenterology
  • General Medicine
  • Haematology
  • Hepatology
  • Infectious Diseases
  • Metabolic Disorders
  • Neurology
  • Nursing
  • Obstetrics & Gynaecology
  • Oncology
  • Paediatrics
  • Psychiatry
  • Rheumatology
  • Surgery Insights
  • Urology

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2026 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa